📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Alemtuzumab for the treatment of multiple sclerosis. (2015)

First Author: Willis MD

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/tcrm.s80112

PubMed Identifier: 25848299

Publication URI: http://europepmc.org/abstract/MED/25848299

Type: Journal Article/Review

Volume: 11

Parent Publication: Therapeutics and clinical risk management

ISSN: 1176-6336